Table 1.
Clinical Characteristic | Patients (N=152) | ||||||
---|---|---|---|---|---|---|---|
Total (n=152) | RT (n=40) | No RT (n=112) | p-value | ||||
No. | % | No. | % | No. | % | ||
Age, years | 0.737 | ||||||
Mean | 43.1 | 43.5 | 42.9 | ||||
Range | 21–68 | 21–66 | 21–68 | ||||
Stage (FIGO) | 0.003 | ||||||
I | 126 | 82.9 | 27 | 67.5 | 99 | 88.4 | |
II | 26 | 17.1 | 13 | 32.5 | 13 | 11.6 | |
Menstruation status | 0.315 | ||||||
Premenopausal | 134 | 88.2 | 33 | 17.5 | 101 | 9.8 | |
Postmenopausal | 18 | 11.8 | 7 | 82.5 | 11 | 90.2 | |
Pathologic tumor size, cm | 0.427 | ||||||
mean | 6.5 | 6.8 | 6.4 | ||||
Range | 1.4–17 | 3.0–15.0 | 1.4–17.0 | ||||
Ovary preservation | 0.081 | ||||||
Yes | 34 | 22.4 | 5 | 12.5 | 29 | 25.9 | |
No | 118 | 77.6 | 35 | 87.5 | 83 | 74.1 | |
Hormonal therapy | 0.155 | ||||||
Yes | 69 | 45.4 | 22 | 55.0 | 47 | 42.0 | |
No | 83 | 54.6 | 18 | 45.0 | 65 | 58.0 | |
Chemotherapy | 0.451 | ||||||
Yes | 14 | 9.2 | 2 | 5.0 | 12 | 10.7 | |
No | 138 | 90.8 | 38 | 95.0 | 100 | 89.3 |
RT, radiotherapy; FIGO, International Federation of Gynecology and Obstetrics.